{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:43:34Z","timestamp":1790891014695,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences","award":["2019PT320015"],"award-info":[{"award-number":["2019PT320015"]}]},{"DOI":"10.13039\/501100020770","name":"Young Medical Key Talents Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["ZDRCA2016097"],"award-info":[{"award-number":["ZDRCA2016097"]}],"id":[{"id":"10.13039\/501100020770","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-024-01148-w","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T14:00:58Z","timestamp":1733493658000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Establishment of two novel organoid lines from patients with combined hepatocellular cholangiocarcinoma"],"prefix":"10.1007","volume":"38","author":[{"given":"Yun","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuerong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suiqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyong","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5849-0098","authenticated-orcid":false,"given":"Xuehao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"key":"1148_CR1","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.jhep.2021.01.035","volume":"74","author":"A Beaufr\u00e8re","year":"2021","unstructured":"Beaufr\u00e8re A, Calderaro J, Paradis V. Combined hepatocellular-cholangiocarcinoma: An update. J Hepatol. 2021;74:1212\u201324.","journal-title":"J Hepatol"},{"key":"1148_CR2","first-page":"210","volume":"12","author":"KJ Chu","year":"2024","unstructured":"Chu KJ, Kawaguchi Y, Wang H, Jiang XQ, Hasegawa K. Update on the diagnosis and treatment of combined hepatocellular cholangiocarcinoma. J Clin Transl Hepatol. 2024;12:210\u20137.","journal-title":"J Clin Transl Hepatol"},{"key":"1148_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.humpath.2019.11.001","volume":"96","author":"A Sciarra","year":"2020","unstructured":"Sciarra A, Park YN, Sempoux C. Updates in the diagnosis of combined hepatocellular-cholangiocarcinoma. Hum Pathol. 2020;96:48\u201355.","journal-title":"Hum Pathol"},{"key":"1148_CR4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1055\/s-0039-3402515","volume":"40","author":"M Komuta","year":"2020","unstructured":"Komuta M, Yeh MM. A review on the update of combined hepatocellular cholangiocarcinoma. Semin Liver Dis. 2020;40:124\u201330.","journal-title":"Semin Liver Dis"},{"key":"1148_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000530700","volume":"13","author":"L Ye","year":"2024","unstructured":"Ye L, Schneider JS, Ben Khaled N, et al. Combined hepatocellular-cholangiocarcinoma: biology, diagnosis, and management. Liver Cancer. 2024;13:6\u201328.","journal-title":"Liver Cancer."},{"key":"1148_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0168-8278(96)80161-9","volume":"24","author":"H Yano","year":"1996","unstructured":"Yano H, Iemura A, Haramaki M, et al. A human combined hepatocellular and cholangiocarcinoma cell line (KMCH-2) that shows the features of hepatocellular carcinoma or cholangiocarcinoma under different growth conditions. J Hepatol. 1996;24:413\u201322.","journal-title":"J Hepatol"},{"key":"1148_CR7","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/hep.1840070322","volume":"7","author":"T Murakami","year":"1987","unstructured":"Murakami T, Yano H, Maruiwa M, Sugihara S, Kojiro M. Establishment and characterization of a human combined hepatocholangiocarcinoma cell line and its heterologous transplantation in nude mice. Hepatology. 1987;7:551\u20136.","journal-title":"Hepatology"},{"issue":"2","key":"1148_CR8","doi-asserted-by":"publisher","first-page":"118","DOI":"10.2174\/0115680096285910240206044830","volume":"25","author":"Z Atl\u0131 \u015eekero\u011flu","year":"2024","unstructured":"Atl\u0131 \u015eekero\u011flu Z, \u015eekero\u011flu V. A review on patient-derived 3D micro cancer approach for drug screen in personalized cancer medicine. Curr Cancer Drug Targets. 2024;25(2):118\u201330.","journal-title":"Curr Cancer Drug Targets"},{"key":"1148_CR9","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.chembiol.2017.06.012","volume":"24","author":"F Weeber","year":"2017","unstructured":"Weeber F, Ooft SN, Dijkstra KK, Voest EE. Tumor organoids as a pre-clinical cancer model for drug discovery. Cell Chem Biol. 2017;24:1092\u2013100.","journal-title":"Cell Chem Biol"},{"key":"1148_CR10","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/hep.31653","volume":"74","author":"K Sato","year":"2021","unstructured":"Sato K, Zhang W, Safarikia S, et al. Organoids and spheroids as models for studying cholestatic liver injury and cholangiocarcinoma. Hepatology. 2021;74:491\u2013502.","journal-title":"Hepatology"},{"key":"1148_CR11","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4438","volume":"23","author":"L Broutier","year":"2017","unstructured":"Broutier L, Mastrogiovanni G, Verstegen MM, et al. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. Nat Med. 2017;23:1424\u201335.","journal-title":"Nat Med"},{"key":"1148_CR12","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/stem.2275","volume":"34","author":"Y Gao","year":"2016","unstructured":"Gao Y, Zhou Z, Lu S, et al. Chemokine CCL15 mediates migration of human bone marrow-derived mesenchymal stem cells toward hepatocellular carcinoma. Stem Cells. 2016;34:1112\u201322.","journal-title":"Stem Cells"},{"key":"1148_CR13","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.jhep.2022.07.019","volume":"77","author":"J Calderaro","year":"2022","unstructured":"Calderaro J, Di Tommaso L, Maill\u00e9 P, et al. Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma. J Hepatol. 2022;77:1586\u201397.","journal-title":"J Hepatol"},{"key":"1148_CR14","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/his.14622","volume":"80","author":"M Sasaki","year":"2022","unstructured":"Sasaki M, Sato Y, Nakanuma Y. Is nestin a diagnostic marker for combined hepatocellular-cholangiocarcinoma? Histopathology. 2022;80:859\u201368.","journal-title":"Histopathology"},{"key":"1148_CR15","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.ccell.2019.04.007","volume":"35","author":"R Xue","year":"2019","unstructured":"Xue R, Chen L, Zhang C, et al. Genomic and transcriptomic profiling of combined hepatocellular and intrahepatic cholangiocarcinoma reveals distinct molecular subtypes. Cancer Cell. 2019;35:932-947.e938.","journal-title":"Cancer Cell"},{"key":"1148_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","volume":"172","author":"N Sachs","year":"2018","unstructured":"Sachs N, de Ligt J, Kopper O, et al. A living biobank of breast cancer organoids captures disease heterogeneity. Cell. 2018;172:373-386.e310.","journal-title":"Cell"},{"key":"1148_CR17","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-024-07054-3","volume":"627","author":"L Chen","year":"2024","unstructured":"Chen L, Zhang C, Xue R, et al. Deep whole-genome analysis of 494 hepatocellular carcinomas. Nature. 2024;627:586\u201393.","journal-title":"Nature"},{"key":"1148_CR18","unstructured":"Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017;169:1327\u20131341.e1323. https:\/\/pubmed.ncbi.nlm.nih.gov\/28622513."},{"key":"1148_CR19","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/ng.804","volume":"43","author":"Y Totoki","year":"2011","unstructured":"Totoki Y, Tatsuno K, Yamamoto S, et al. High-resolution characterization of a hepatocellular carcinoma genome. Nat Genet. 2011;43:464\u20139.","journal-title":"Nat Genet"},{"key":"1148_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2023.100898","volume":"28","author":"Z Yang","year":"2023","unstructured":"Yang Z, Liu J, Xue F, Zhang L, Xue H, Wu Y, Bai S, et al. Genomic landscape of Chinese patients with hepatocellular carcinoma using next-generation sequencing and its association with the prognosis. Ann Hepatol. 2023;28: 100898.","journal-title":"Ann Hepatol"},{"key":"1148_CR21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12967-020-02437-2","volume":"18","author":"L Wang","year":"2020","unstructured":"Wang L, Zhu H, Zhao Y, et al. Comprehensive molecular profiling of intrahepatic cholangiocarcinoma in the Chinese population and therapeutic experience. J Transl Med. 2020;18:273.","journal-title":"J Transl Med"},{"issue":"1","key":"1148_CR22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/ijms25010461","volume":"25","author":"W Andraus","year":"2023","unstructured":"Andraus W, Tustumi F, de Meira Junior JD, et al. Molecular profile of intrahepatic cholangiocarcinoma. Int J Mol Sci. 2023;25(1):461.","journal-title":"Int J Mol Sci"},{"key":"1148_CR23","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/path.5243","volume":"248","author":"NM Joseph","year":"2019","unstructured":"Joseph NM, Tsokos CG, Umetsu SE, et al. Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma. J Pathol. 2019;248:164\u201378.","journal-title":"J Pathol"},{"key":"1148_CR24","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s13402-022-00707-3","volume":"45","author":"L Xian","year":"2022","unstructured":"Xian L, Zhao P, Chen X, et al. Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer. Cell Oncol (Dordr). 2022;45:1019\u201336.","journal-title":"Cell Oncol (Dordr)"},{"key":"1148_CR25","doi-asserted-by":"publisher","first-page":"112987","DOI":"10.1016\/j.yexcr.2021.112987","volume":"411","author":"JH Yu","year":"2022","unstructured":"Yu JH, Ma S. Organoids as research models for hepatocellular carcinoma. Exp Cell Res. 2022;411:112987.","journal-title":"Exp Cell Res"},{"key":"1148_CR26","doi-asserted-by":"publisher","first-page":"goae031","DOI":"10.1093\/gastro\/goae031","volume":"12","author":"YZ Zhang","year":"2024","unstructured":"Zhang YZ, Liu YC, Su T, Shi JN, Huang Y, Liang B. Current advances and future directions in combined hepatocellular and cholangiocarcinoma. Gastroenterol Rep (Oxf). 2024;12:goae031.","journal-title":"Gastroenterol Rep (Oxf)."}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-024-01148-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-024-01148-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-024-01148-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T03:26:23Z","timestamp":1736393183000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-024-01148-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["1148"],"URL":"https:\/\/doi.org\/10.1007\/s13577-024-01148-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4935983\/v1","asserted-by":"object"}]},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,6]]},"assertion":[{"value":"19 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Nothing to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study involving human tissues was approved by the Ethics Committee of Nanjing Medical University, and the patients provided written informed consents. All animal experiments adhered to the guidelines of the Institutional Animal Care and Use Committee of Nanjing Medical University and were approved by the Animal Experimentation Ethics Committee of Nanjing Medical University (permission number 2019-SRFA-238).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"27"}}